CX3CR1 and Parkinson disease: These findings underscore the importance of CX3CR1 signaling in regulating microglial phenotype and inflammatory cascades during PD progression, particularly in the context of α-synuclein mutations, such as A53T (Castro-Sánchez et al., 2018).